Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

BACKGROUND: Predicting metastasis in melanoma patients is important for disease management and could help to identify those who might benefit from adjuvant treatment. The aim of this study was to investigate whether the tumor microenvironment-derived protein S100A8/A9 qualifies as prognostic marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Nikolaus B., Weide, Benjamin, Gries, Mirko, Reith, Maike, Tarnanidis, Kathrin, Schuermans, Valerie, Kemper, Charlotte, Kehrel, Coretta, Funder, Anne, Lichtenberger, Ramtin, Sucker, Antje, Herpel, Esther, Holland-Letz, Tim, Schadendorf, Dirk, Garbe, Claus, Umansky, Viktor, Utikal, Jochen, Gebhardt, Christoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896585/
https://www.ncbi.nlm.nih.gov/pubmed/31806053
http://dx.doi.org/10.1186/s40425-019-0828-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896585/
https://www.ncbi.nlm.nih.gov/pubmed/31806053
http://dx.doi.org/10.1186/s40425-019-0828-1

Ejemplares similares